Pharmacokinetics of the soluble guanylate cyclase stimulator riociguat in individuals with hepatic impairment

被引：0
|
作者：
Reiner Frey
Corina Becker
Sigrun Unger
Anja Schmidt
Georg Wensing
Wolfgang Mueck
机构：
[1] Clinical Pharmacology,
[2] Bayer Pharma AG,undefined
[3] Pharma Research Centre,undefined
[4] Global Biostatistics,undefined
[5] Bayer Pharma AG,undefined
[6] Pharma Research Centre,undefined
来源：
BMC Pharmacology and Toxicology | / 14卷 / Suppl 1期
关键词：
Pulmonary Hypertension; Liver Cirrhosis; Hepatic Impairment; Oral Tablet; Moderate Hepatic Impairment;
D O I：
10.1186/2050-6511-14-S1-P21
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Soluble guanylate cyclase stimulator riociguat reduces organ damage in experimental models of hypertension
    Stasch, J. P.
    Sharkova, Y.
    Kalk, P.
    Lawrence, B.
    Godes, M.
    Hoffmann, L. S.
    Wellkisch, K.
    Geschka, S.
    Relle, K.
    Hocher, B.
    EUROPEAN HEART JOURNAL, 2010, 31 : 761 - 761
  • [22] Comparison of the crystal structures and thermochemistry of a novel soluble guanylate cyclase stimulator riociguat and its solvates
    Zhou, Xinbo
    Hu, Xiurong
    Gu, Jianming
    Zhu, Jianrong
    ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE CRYSTAL ENGINEERING AND MATERIALS, 2017, 73 : 891 - 898
  • [23] Soluble guanylate cyclase stimulator riociguat improves spatial memory in mice via peripheral mechanisms
    Nelissen, Ellis
    van Hagen, Britt T. J.
    Argyrousi, Elentina K.
    van Goethem, Nick P.
    Heckman, Pim R. A.
    Paes, Dean
    Mulder-Jongen, Danielle A. J.
    Ramaekers, Johannes G.
    Blokland, Arjan
    Schmidt, Harald H. H. W.
    Prickaerts, Jos
    NEUROSCIENCE LETTERS, 2022, 788
  • [24] Riociguat, a soluble guanylate cyclase stimulator, ameliorates right ventricular contraction in pulmonary arterial hypertension
    Murata, Mitsushige
    Kawakami, Takashi
    Kataoka, Masaharu
    Kohno, Takashi
    Itabashi, Yuji
    Fukuda, Keiichi
    PULMONARY CIRCULATION, 2017, 8 (01)
  • [25] The soluble guanylate cyclase stimulator riociguat and the soluble guanylate cyclase activator cinaciguat exert no direct effects on contractility and relaxation of cardiac myocytes from normal rats
    Reinke, Yvonne
    Gross, Stefan
    Eckerle, Lars G.
    Hertrich, Isabel
    Busch, Mathias
    Busch, Raila
    Riad, Alexander
    Rauch, Bernhard H.
    Stasch, Johannes-Peter
    Doerr, Marcus
    Felix, Stephan B.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2015, 767 : 1 - 9
  • [26] Warfarin pharmacodynamics and pharmacokinetics are not affected by the soluble guanylate cyclase stimulator riociguat (BAY 63-2521): results of a randomized, controlled trial
    Frey, R.
    Mueck, W.
    Kirschbaum, N.
    Kraetzschmar, J.
    Weimann, G.
    Wensing, G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [27] Effects Of The Soluble Guanylate Cyclase Stimulator Riociguat On Emphysema Development In Tobacco-Smoke Exposed Mice
    Seimetz, M.
    Parajuli, N.
    Pichl, A.
    Stasch, J. -P.
    Frey, R.
    Schermuly, R. T.
    Ghofrani, H. A.
    Seeger, W.
    Grimminger, F.
    Weissmann, N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [28] First-in-child use of the oral soluble guanylate cyclase stimulator riociguat in pulmonary arterial hypertension
    Spreemann, Till
    Bertram, Harald
    Happel, Christoph M.
    Kozlik-Feldmann, Rainer
    Hansmann, Georg
    PULMONARY CIRCULATION, 2017, 8 (01)
  • [29] Effects of the soluble guanylate cyclase stimulator riociguat in pressure-overload induced heart failure in mice
    Benkner, A.
    Ruedebusch, J.
    Klingel, K.
    Hammer, E.
    Witt, E.
    Dhople, V. M.
    Doerr, M.
    Felix, S. B.
    Grube, K.
    EUROPEAN HEART JOURNAL, 2017, 38 : 103 - 103
  • [30] Antihypertensive Effects of a Soluble Guanylate Cyclase Stimulator
    V. V. Bykov
    Yu. G. Birulina
    A. V. Nosarev
    A. I. Vengerovskii
    V. V. Udut
    Bulletin of Experimental Biology and Medicine, 2022, 174 : 33 - 36
12345